Table 1.

Characteristics of MELD 35+ Recipients and Reprioritized Candidates

	Share-35 Recipients	Reprioritized Candidates	Comparable Reprioritized Candidates
N	1768	1219	291
Age, med (IQR)	55 (47–61)	58 (51–63)	58 (50–63)
Female	673 (38%)	451 (37%)	117 (40%)
MELD at Export, med (IQR)	-	31 (27–34)	37 (34–38)
MELD at Transplant, med (IQR)	39 (37–40)	31 (27–36)	37 (35–39)
Median (IQR) months on waitlist	0.6 (0.2–5.0)	4.6 (0.8–13)	4.3 (0.5–20)
White	1188 (67%)	848 (70%)	177 (61%)
Black	190 (11%)	110 (9.0%)	30 (10%)
Hispanic	299 (17%)	197 (16%)	68 (23%)
Other	91 (5.2%)	64 (5.3%)	16 (5.5%)
ABO-identical	1573 (89%)	1121 (92%)	267 (92%)
ABO-compatible	164 (9.3%)	98 (8.0%)	24 (8.3%)
ABO-incompatible	31 (1.8%)	-	-

MELD, Model for End-Stage Liver Disease